SCHEMBL6074031

SCHEMBL6074031

CC(N)(O)c1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.47
SCN5A Q14524 3/20 0.45
SCN9A Q15858 3/20 0.45
PGR P06401 1/20 0.45
KIF11 P52732 4/20 0.42
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
PKM P14618 1/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CHRM3 P20309 1/20 0.40
HSD11B1 P28845 1/20 0.40
PARP1 P09874 1/20 0.39
HTR3E A5X5Y0 2/20 0.38
HTR3B O95264 2/20 0.38
HTR3A P46098 2/20 0.38
HTR3D Q70Z44 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27601929 0.98 CYP19A1 (0.46) CYP19A1SCN5ASCN9APGRKIF11
SCHEMBL4294497 0.83 CYP19A1 (0.50) CYP19A1SCN5ASCN9APGRKIF11
SCHEMBL1155523 0.83 CYP19A1 (0.50) CYP19A1SCN5ASCN9APGRKIF11
SCHEMBL1859294 0.83 KIF11 (0.44) CYP19A1SCN5ASCN9APGRKIF11
SCHEMBL7784232 0.81 CYP19A1 (0.49) CYP19A1SCN5ASCN9APGRKIF11
Hydrochloric Acid SCHEMBL16321424 0.81 KIF11 (0.43) CYP19A1SCN5ASCN9APGRKIF11
SCHEMBL3356661 0.80 ALDH1A1 (0.50) CYP19A1SCN5ASCN9AKIF11ALDH1A1
SCHEMBL3960158 0.79 KIF11 (0.45) CYP19A1SCN5ASCN9APGRKIF11
SCHEMBL21264407 0.79 KIF11 (0.45) CYP19A1SCN5ASCN9APGRKIF11
Metaglycodol SCHEMBL2108213 0.79 CYP19A1 (0.47) CYP19A1SCN5ASCN9APGRKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7022716-B2 Cyclic amine phenyl beta-3 adrenergic receptor agonists WYETH (US) 2006-04-04 US disclosed
US-20030144326-A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists WYETH 2003-07-31 US disclosed
CN-1034497-C Process for the preparation of aromatic aminoalcohol derivatives useful for the treatment of diabetes and obesity SANKYO CO (JP) 1997-04-09 CN disclosed
CN-1073428-A Aromatic amino alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic use SANKYO CO (JP) 1993-06-23 CN disclosed
EP-0061907-B1 SECONDARY AMINES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE BEECHAM GROUP PLC (GB) 1984-08-01 EP disclosed
EP-0061907-A1 Secondary amines, their preparation, pharmaceutical compositions containing them and their use BEECHAM GROUP PLC (GB) 1982-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144326-A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists ADRB1, ADRB3, ADRB2 CYP19A1 1357/4885SCN5A 860/4885SCN9A 2193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.